Schedule 13G ownership disclosure

Arcutis Biotherapeutics Inc

Common Stock, par value $0.0001 · CUSIP: 03969K108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Polar Capital Holdings Plc

    Shares: 5,006,472.00 · Class: 4.2%

  • Polar Capital LLP

    Shares: 5,006,472.00 · Class: 4.2%

  • Polar Capital Funds PLC - Biotechnology Fund

    Shares: 5,006,472.00 · Class: 4.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-003250
Form type
SCHEDULE 13G/A
Filer
Arcutis Biotherapeutics, Inc.
CIK
CIK 1787306
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub